• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血吸虫对替代补体途径的宿主特异性逃避与一种类似于人类衰变加速因子的磷脂酶C敏感表面分子的存在相关。

Host-specific evasion of the alternative complement pathway by schistosomes correlates with the presence of a phospholipase C-sensitive surface molecule resembling human decay accelerating factor.

作者信息

Pearce E J, Hall B F, Sher A

机构信息

Immunology and Cell Biology Section, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.

出版信息

J Immunol. 1990 Apr 1;144(7):2751-6.

PMID:1690776
Abstract

Schistosoma mansoni parasites recovered from the blood stream were found to be nonactivators of the alternative complement pathway (ACP) when exposed to sera of homologous but not heterologous host species. Schistosomes could be converted into activators of the homologous ACP by treatment with phospholipase C. Antibodies to either human or guinea pig decay accelerating factor (DAF), a 70-kDa glycosylphosphatidylinositol anchored membrane glycoprotein which controls ACP activation on the mammalian cell plasma membrane, bound to the surface of immature schistosomes and immunoprecipitated a molecule of similar molecular mass from detergent extracts of surface iodinated parasites. Phospholipase C treatment drastically reduced the reactivity of the worms with the anti-DAF antibodies. These data suggest that schistosomes evade the ACP by inserting functional host DAF into their surfaces, possibly through adsorption of the molecule's lipophilic diacyglycerol membrane anchor moiety into the outer lipid bilayer of the parasite.

摘要

从血流中回收的曼氏血吸虫寄生虫在暴露于同源而非异源宿主物种的血清时,被发现是非替代补体途径(ACP)的激活剂。通过用磷脂酶C处理,血吸虫可转化为同源ACP的激活剂。针对人或豚鼠衰变加速因子(DAF)的抗体,一种控制哺乳动物细胞质膜上ACP激活的70 kDa糖基磷脂酰肌醇锚定膜糖蛋白,与未成熟血吸虫的表面结合,并从表面碘化寄生虫的去污剂提取物中免疫沉淀出一个分子量相似的分子。磷脂酶C处理大大降低了蠕虫与抗DAF抗体的反应性。这些数据表明,血吸虫可能通过将功能性宿主DAF插入其表面来逃避ACP,这可能是通过将该分子的亲脂性二酰甘油膜锚定部分吸附到寄生虫的外脂质双层中实现的。

相似文献

1
Host-specific evasion of the alternative complement pathway by schistosomes correlates with the presence of a phospholipase C-sensitive surface molecule resembling human decay accelerating factor.血吸虫对替代补体途径的宿主特异性逃避与一种类似于人类衰变加速因子的磷脂酶C敏感表面分子的存在相关。
J Immunol. 1990 Apr 1;144(7):2751-6.
2
The influence of membrane components on regulation of alternative pathway activation by decay-accelerating factor.膜成分对衰变加速因子调节替代途径激活的影响。
J Immunol. 1990 Dec 1;145(11):3836-41.
3
Decay accelerating factor regulates complement activation on glomerular epithelial cells.衰变加速因子调节肾小球上皮细胞上的补体激活。
J Immunol. 1989 Feb 1;142(3):877-82.
4
Human recombinant soluble decay accelerating factor inhibits complement activation in vitro and in vivo.
J Immunol. 1992 Sep 1;149(5):1736-43.
5
Role of human decay-accelerating factor in the evasion of Schistosoma mansoni from the complement-mediated killing in vitro.人类衰变加速因子在曼氏血吸虫体外逃避补体介导杀伤中的作用
J Exp Med. 1991 Dec 1;174(6):1399-406. doi: 10.1084/jem.174.6.1399.
6
Activation of complement by Schistosoma mansoni schistosomula: killing of parasites by the alternative pathway and requirement of IgG for classical pathway activation.曼氏血吸虫童虫对补体的激活:通过替代途径杀伤寄生虫以及经典途径激活对IgG的需求
J Immunol. 1979 Oct;123(4):1551-7.
7
Murine membrane inhibitor of complement which accelerates decay of human C3 convertase.加速人C3转化酶衰变的小鼠补体膜抑制剂。
Immunology. 1989 Dec;68(4):439-44.
8
Evasion of the alternative complement pathway by metacyclic trypomastigotes of Trypanosoma cruzi: dependence on the developmentally regulated synthesis of surface protein and N-linked carbohydrate.克氏锥虫循环后期锥鞭毛体对替代补体途径的逃避:对表面蛋白和 N-连接碳水化合物发育调控合成的依赖性。
J Immunol. 1986 Nov 1;137(9):2961-7.
9
Prevention of complement activation on the homologous cell membrane of nucleated cells as well as erythrocytes.防止补体在有核细胞以及红细胞的同源细胞膜上激活。
Eur J Immunol. 1983 Apr;13(4):340-4. doi: 10.1002/eji.1830130413.
10
Complement activation induces the expression of decay-accelerating factor on human mesangial cells.补体激活诱导人系膜细胞上衰变加速因子的表达。
J Immunol. 1991 Dec 1;147(11):3901-8.

引用本文的文献

1
(Patho)Physiology of Glycosylphosphatidylinositol-Anchored Proteins II: Intercellular Transfer of Matter (Inheritance?) That Matters.糖基磷脂酰肌醇锚定蛋白的病理生理学 II:物质的细胞间转移(遗传?)至关重要。
Biomolecules. 2023 Jun 15;13(6):994. doi: 10.3390/biom13060994.
2
Schistosome immunomodulators.血吸虫免疫调节剂。
PLoS Pathog. 2021 Dec 30;17(12):e1010064. doi: 10.1371/journal.ppat.1010064. eCollection 2021 Dec.
3
Schistosomiasis-from immunopathology to vaccines.血吸虫病:从免疫病理学到疫苗。
Semin Immunopathol. 2020 Jun;42(3):355-371. doi: 10.1007/s00281-020-00789-x. Epub 2020 Feb 19.
4
How schistosomes alter the human serum proteome.血吸虫如何改变人类血清蛋白质组。
Mol Biochem Parasitol. 2017 Jul;215:40-46. doi: 10.1016/j.molbiopara.2016.12.007. Epub 2016 Dec 21.
5
Non-immune immunoglobulins shield Schistosoma japonicum from host immunorecognition.非免疫球蛋白可保护日本血吸虫免受宿主免疫识别。
Sci Rep. 2015 Aug 24;5:13434. doi: 10.1038/srep13434.
6
Eliminating Schistosomes through Vaccination: What are the Best Immune Weapons?通过疫苗接种消灭血吸虫:最佳免疫武器是什么?
Front Immunol. 2015 Mar 9;6:95. doi: 10.3389/fimmu.2015.00095. eCollection 2015.
7
On the three-finger protein domain fold and CD59-like proteins in Schistosoma mansoni.曼氏血吸虫中的三指蛋白结构域折叠和 CD59 样蛋白。
PLoS Negl Trop Dis. 2013 Oct 24;7(10):e2482. doi: 10.1371/journal.pntd.0002482. eCollection 2013.
8
Immune effector mechanisms against schistosomiasis: looking for a chink in the parasite's armour.针对血吸虫病的免疫效应机制:探寻寄生虫防御体系中的薄弱环节
Trends Parasitol. 2009 Sep;25(9):423-31. doi: 10.1016/j.pt.2009.05.011. Epub 2009 Aug 28.
9
Subversion of complement by hematophagous parasites.吸血寄生虫对补体的破坏
Dev Comp Immunol. 2009;33(1):5-13. doi: 10.1016/j.dci.2008.07.010.
10
Aberrant receptor-mediated endocytosis of Schistosoma mansoni glycoproteins on host lipoproteins.曼氏血吸虫糖蛋白在宿主脂蛋白上异常的受体介导内吞作用。
PLoS Med. 2006 Aug;3(8):e253. doi: 10.1371/journal.pmed.0030253.